Diabetes, Liver Cancer, and Cirrhosis: What Next?

Research output: Contribution to journalEditorialScientificpeer-review

Original languageEnglish
JournalHepatology
Volume68
Issue number4
Pages (from-to)1220-1222
Number of pages3
ISSN0270-9139
DOIs
Publication statusPublished - Oct 2018
MoE publication typeA1 Journal article-refereed

Fields of Science

  • BODY-MASS INDEX
  • HEPATOCELLULAR-CARCINOMA
  • RISK
  • FIBROSIS
  • 3121 Internal medicine

Cite this

@article{a3505fbfbc3344cd9b4dc9a889a2316e,
title = "Diabetes, Liver Cancer, and Cirrhosis: What Next?",
keywords = "BODY-MASS INDEX, HEPATOCELLULAR-CARCINOMA, RISK, FIBROSIS, 3121 Internal medicine",
author = "Hannele Yki-J{\"a}rvinen and Luukkonen, {Panu K.}",
year = "2018",
month = "10",
doi = "10.1002/hep.30136",
language = "English",
volume = "68",
pages = "1220--1222",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley & Sons Ltd.",
number = "4",

}

Diabetes, Liver Cancer, and Cirrhosis : What Next? / Yki-Järvinen, Hannele; Luukkonen, Panu K.

In: Hepatology, Vol. 68, No. 4, 10.2018, p. 1220-1222.

Research output: Contribution to journalEditorialScientificpeer-review

TY - JOUR

T1 - Diabetes, Liver Cancer, and Cirrhosis

T2 - What Next?

AU - Yki-Järvinen, Hannele

AU - Luukkonen, Panu K.

PY - 2018/10

Y1 - 2018/10

KW - BODY-MASS INDEX

KW - HEPATOCELLULAR-CARCINOMA

KW - RISK

KW - FIBROSIS

KW - 3121 Internal medicine

U2 - 10.1002/hep.30136

DO - 10.1002/hep.30136

M3 - Editorial

VL - 68

SP - 1220

EP - 1222

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 4

ER -